- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 125.68M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $178.38M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $185.51M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $643.07M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $656.51M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $727.72M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $788.95M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $807.29M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $885.05M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $411.29M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $325.92M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 122.96M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $293K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$132.98M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $266.68M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $194.52M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.54 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.54 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $129.51M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $84.7M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$66.42M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$62.09M |
| Revenue | Q1 2025 · Mar 31, 2024 | $172.33M |